• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Are We Now Able to Define Guidelines for Moderate Hypofractionation in Prostate Cancer Radiation Therapy?

作者信息

Brenner David J, Hall Eric J

机构信息

Center for Radiological Research, Department of Radiation Oncology, Columbia University Medical Center, New York, New York.

Center for Radiological Research, Department of Radiation Oncology, Columbia University Medical Center, New York, New York.

出版信息

Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):871-873. doi: 10.1016/j.ijrobp.2017.12.274.

DOI:10.1016/j.ijrobp.2017.12.274
PMID:29485065
Abstract
摘要

相似文献

1
Are We Now Able to Define Guidelines for Moderate Hypofractionation in Prostate Cancer Radiation Therapy?我们现在是否能够确定前列腺癌放射治疗中适度低分割放疗的指南？
Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):871-873. doi: 10.1016/j.ijrobp.2017.12.274.
2
Moderate hypofractionation and stereotactic body radiation therapy in the treatment of prostate cancer.中分割立体定向放射治疗前列腺癌。
Urol Oncol. 2019 Sep;37(9):619-627. doi: 10.1016/j.urolonc.2019.01.015. Epub 2019 Feb 7.
3
Important Technical Considerations for Implementing the ASTRO/ASCO/AUA Prostate Cancer Hypofractionated Radiation Guideline.实施美国放射肿瘤学会（ASTRO）/美国临床肿瘤学会（ASCO）/美国泌尿外科学会（AUA）前列腺癌大分割放疗指南的重要技术考量
Pract Radiat Oncol. 2019 Jul-Aug;9(4):197-199. doi: 10.1016/j.prro.2019.02.017. Epub 2019 Mar 2.
4
Breast, Prostate, and Rectal Cancer: Should 5-5-5 Be a New Standard of Care?乳腺癌、前列腺癌和直肠癌：5-5-5应成为新的护理标准吗？
Int J Radiat Oncol Biol Phys. 2020 Oct 1;108(2):390-393. doi: 10.1016/j.ijrobp.2020.06.049.
5
Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based Guideline.局限性前列腺癌的分割放疗：ASTRO、ASCO 和 AUA 循证指南的执行摘要。
Pract Radiat Oncol. 2018 Nov-Dec;8(6):354-360. doi: 10.1016/j.prro.2018.08.002. Epub 2018 Oct 11.
6
Rationale for hypofractionation.大分割放疗的原理。
Cancer Radiother. 2019 Oct;23(6-7):500-502. doi: 10.1016/j.canrad.2019.07.156. Epub 2019 Aug 20.
7
Ultrahypofractionation Should be a Standard of Care Option for Intermediate-Risk Prostate Cancer.超高分割放疗应成为中危前列腺癌的一种标准治疗选择。
Clin Oncol (R Coll Radiol). 2020 Mar;32(3):170-174. doi: 10.1016/j.clon.2019.11.004. Epub 2019 Nov 28.
8
Are we ready for a paradigm shift from high-dose conventional to moderate hypofractionated radiotherapy in intermediate-high risk prostate cancer? A systematic review of randomized controlled trials with trial sequential analysis.我们是否准备好在中高危前列腺癌中从高剂量常规放疗转向中低剂量超分割放疗的范式转变？一项使用试验序贯分析的随机对照试验的系统评价。
Crit Rev Oncol Hematol. 2019 Jul;139:75-82. doi: 10.1016/j.critrevonc.2019.04.012. Epub 2019 Apr 27.
9
How will the CHHiP trial affect the future of prostate radiotherapy?CHHiP试验将如何影响前列腺癌放疗的未来？
Expert Rev Anticancer Ther. 2018 Jul;18(7):607-609. doi: 10.1080/14737140.2018.1477595. Epub 2018 May 25.
10
SBRT for Localized Prostate Cancer: Is it Ready for Take-Off?局部前列腺癌的立体定向体部放疗：它准备好腾飞了吗？
Int J Radiat Oncol Biol Phys. 2019 Nov 1;105(3):618-620. doi: 10.1016/j.ijrobp.2019.07.008.

引用本文的文献

1
Image-guided moderately hypofractionated radiotherapy for localized prostate cancer: a multicentric retrospective study (IPOPROMISE).图像引导的中度低分割放射治疗局限性前列腺癌：多中心回顾性研究（IPOPROMISE）。
Radiol Med. 2024 Apr;129(4):643-652. doi: 10.1007/s11547-024-01782-2. Epub 2024 Feb 19.
2
Hypofractionated Radiotherapy in Localized, Low-Intermediate-Risk Prostate Cancer: Current and Future Prospectives.局部低中危前列腺癌的适形分割放疗：现状与未来展望。
Medicina (Kaunas). 2023 Jun 14;59(6):1144. doi: 10.3390/medicina59061144.
3
Safety of accelerated hypofractionated whole pelvis radiation therapy prior to high dose rate brachytherapy or stereotactic body radiation therapy prostate boost.
加速Hypofractionated 全骨盆放射治疗在高剂量率近距离治疗或立体定向体部放射治疗前列腺加量之前的安全性。
Radiat Oncol. 2022 Jan 20;17(1):12. doi: 10.1186/s13014-021-01976-2.
4
Practical considerations for prostate hypofractionation in the developing world.发展中国家前列腺低分割放疗的实际考虑因素。
Nat Rev Urol. 2021 Nov;18(11):669-685. doi: 10.1038/s41585-021-00498-6. Epub 2021 Aug 13.
5
Moderately Hypofractionated Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Prostate Cancer: Five-Year Toxicity Results From a Prospective Phase I/II Trial.前列腺癌同步整合加量的中度分割调强放射治疗：一项前瞻性I/II期试验的五年毒性结果
Front Oncol. 2020 Aug 21;10:1686. doi: 10.3389/fonc.2020.01686. eCollection 2020.
6
Moderate hypofractionated radiotherapy vs conventional fractionated radiotherapy in localized prostate cancer: a systemic review and meta-analysis from Phase III randomized trials.局部前列腺癌中适度低分割放疗与传统分割放疗的比较：来自III期随机试验的系统评价和荟萃分析
Onco Targets Ther. 2019 Feb 15;12:1259-1268. doi: 10.2147/OTT.S181067. eCollection 2019.